201 related articles for article (PubMed ID: 30062683)
1. Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management.
McCaughan JA; Tinckam KJ
Transpl Int; 2018 Oct; 31(10):1059-1070. PubMed ID: 30062683
[TBL] [Abstract][Full Text] [Related]
2. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
[TBL] [Abstract][Full Text] [Related]
3. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
Huang Y; Ramon D; Luan FL; Sung R; Samaniego M
Clin Transpl; 2012; ():247-56. PubMed ID: 23721029
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
Caillard S; Becmeur C; Gautier-Vargas G; Olagne J; Muller C; Cognard N; Perrin P; Braun L; Heibel F; Lefebre F; Renner V; Gachet C; Moulin B; Parissiadis A
Transpl Int; 2017 Jan; 30(1):29-40. PubMed ID: 27678382
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
6. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver.
Abu-Elmagd KM; Wu G; Costa G; Lunz J; Martin L; Koritsky DA; Murase N; Irish W; Zeevi A
Am J Transplant; 2012 Nov; 12(11):3047-60. PubMed ID: 22947059
[TBL] [Abstract][Full Text] [Related]
7. Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors.
Perbos E; Juinier E; Guidicelli G; Dromer C; Merville P; Billes MA; Taupin JL; Neau-Cransac M
Clin Transplant; 2014 Sep; 28(9):1054-60. PubMed ID: 25040585
[TBL] [Abstract][Full Text] [Related]
8. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
Abuhelaiqa E; Friedlander R; Aull M; Putheti P; Sharma V; Suthanthiran M; Dadhania D
Clin Transpl; 2016; 32():83-91. PubMed ID: 28564525
[TBL] [Abstract][Full Text] [Related]
9. From Humoral Theory to Performant Risk Stratification in Kidney Transplantation.
Lefaucheur C; Viglietti D; Mangiola M; Loupy A; Zeevi A
J Immunol Res; 2017; 2017():5201098. PubMed ID: 28133619
[TBL] [Abstract][Full Text] [Related]
10. Donor-Specific HLA Antibodies: A Review of Data Published in 2016.
Idica A; Everly MJ
Clin Transpl; 2016; 32():13-22. PubMed ID: 28564519
[TBL] [Abstract][Full Text] [Related]
11. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
[TBL] [Abstract][Full Text] [Related]
12. Limited impact of pre-existing donor specific HLA-antibodies (DSA) on long term allograft survival after first adult liver transplantation.
Koch M; Marget M; Sterneck M; Fischer L; Thude H; Nashan B
Hum Immunol; 2018 Jul; 79(7):545-549. PubMed ID: 29669260
[TBL] [Abstract][Full Text] [Related]
13. HLA antibodies are associated with deterioration of kidney allograft function irrespective of donor specificity.
von Moos S; Cippà PE; van Breemen R; Mueller TF
Hum Immunol; 2021 Jan; 82(1):19-24. PubMed ID: 33162184
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
16. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
Cheng EY; Kaneku H; Farmer DG
Clin Transpl; 2014; ():153-9. PubMed ID: 26281140
[TBL] [Abstract][Full Text] [Related]
17. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
[TBL] [Abstract][Full Text] [Related]
19. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Hum Immunol; 2017 Sep; 78(9):526-533. PubMed ID: 28732720
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of HLA antibody monitoring after kidney transplantation.
Morath C; Opelz G; Zeier M; Süsal C
J Immunol Res; 2014; 2014():845040. PubMed ID: 25374891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
